Medcaptain Medical Technology Co., Ltd. (HKG:2041)
Hong Kong · Delayed Price · Currency is HKD 8.78
-0.24 (-2.61%)
Sep 11, 2026, 4:08 PM HKT
HKG:2041 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Net Income | 40.76 | 48.89 | -96.4 | -63.71 |
Depreciation & Amortization | 116.34 | 114.72 | 117.16 | 112.19 |
Other Amortization | 6.39 | 4.98 | 5.12 | 3.64 |
Loss (Gain) From Sale of Assets | -0.26 | 0.02 | -0.56 | -0.2 |
Loss (Gain) From Sale of Investments | 1.95 | 1.32 | 0.38 | -1.01 |
Loss (Gain) on Equity Investments | - | - | 0.9 | 1.27 |
Stock-Based Compensation | 83.93 | 67.88 | 53.82 | 64.12 |
Other Operating Activities | 19.14 | 9.61 | 15.7 | 2.93 |
Change in Accounts Receivable | -18.23 | -33.95 | -30.06 | -4.41 |
Change in Inventory | -18.36 | -26.7 | -3.67 | -8.51 |
Change in Accounts Payable | 46.99 | 14.95 | 65.28 | -1.76 |
Change in Unearned Revenue | 4.41 | 17.31 | 48.56 | -12.61 |
Change in Other Net Operating Assets | -26.02 | -15.23 | 7.12 | -27.09 |
Operating Cash Flow | 257.05 | 203.79 | 183.35 | 64.85 |
Operating Cash Flow Growth | - | 11.15% | 182.75% | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Capital Expenditures | -77.36 | -90.74 | -120.14 | -79.65 |
Sale of Property, Plant & Equipment | 0 | 0.37 | 2.07 | 3.14 |
Cash Acquisitions | -5.76 | -5.76 | -18.1 | - |
Sale (Purchase) of Intangibles | -6.23 | -7.72 | -14.75 | -10.59 |
Investment in Securities | 60.42 | 14.07 | 32.57 | -174.09 |
Other Investing Activities | - | - | - | 0.76 |
Investing Cash Flow | -28.93 | -89.78 | -118.35 | -260.42 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Long-Term Debt Issued | - | 177.48 | 87.56 | 188.65 |
Long-Term Debt Repaid | - | -256.46 | -206.77 | -193.98 |
Lease Payments | -28.99 | -26.56 | -27.87 | -27.17 |
Net Debt Issued (Repaid) | -85.69 | -78.97 | -119.21 | -5.33 |
Issuance of Common Stock | - | - | 92.37 | 155.08 |
Other Financing Activities | -20.63 | -20.09 | -20.08 | -22.48 |
Financing Cash Flow | -106.32 | -99.07 | -46.92 | 127.27 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Foreign Exchange Rate Adjustments | -8.66 | 2.32 | 3.64 | 13.22 |
Net Cash Flow | 113.14 | 17.27 | 21.72 | -55.08 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Free Cash Flow | 179.69 | 113.06 | 63.21 | -14.8 |
Free Cash Flow Growth | - | 78.86% | - | - |
Free Cash Flow Margin | 10.65% | 6.98% | 4.52% | -1.13% |
Free Cash Flow Per Share | 0.36 | 0.23 | - | - |
Levered Free Cash Flow | - | 76.1 | 56.91 | - |
Unlevered Free Cash Flow | - | 87.56 | 66.91 | - |
Free Cash Flow After Leases | 150.7 | 86.5 | 35.35 | -41.98 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash Interest Paid | 18.52 | 18.44 | 16.15 | 22.28 |
Cash Income Tax Paid | 38.15 | 39.9 | 35.01 | 19.71 |
Change in Working Capital | -11.21 | -43.62 | 87.23 | -54.39 |